Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Wei Zhao
Shiyao Group Ouyi Pharmaceutical Co., Ltd.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Anhui Cancer Hospital
Hefei, Anhui, China
- Maanshan People'S Hospital
Maanshan, Anhui, China
- Hainan General Hospital
Haikou, Hainan, China
- the Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
- Tumor Hospital of Harbin Medical University
Harbin, Heilongjiang, China
- Henan Cancer Hospital
Zhengzhou, Henan, China
- Inner Mongolia Autonomous Region Cancer Hospital
Hohhot, Inner Mongolia, China
- Liaoning Cancer Hospital
Shenyang, Liaoning, China
- Zhongshan Hospital
Shanghai, Shanghai Municipality, China
- Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, China
- the First Affiliated Hospital of Xi'An Jiaotong University
Xi’an, Shanxi, China
- the Second Affiliated Hospital of Xi'An Jiaotong University (xibei Hospital)
Xi’an, Shanxi, China
- the Second Affiliated Hospital Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
- Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 May 2020
- Primary completion
- 1 Feb 2024
- Completion
- 1 Feb 2024
- Last update posted
- 28 Feb 2024
- Registered enrollment
- 1,000
- Registry id
- NCT04060290
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.